EIM
OSIR

Essex Investment Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Essex Investment Management’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-68,083
Closed -$1.09M – 400
2013
Q4 		$1.09M Buy
68,083
+683
+1% +$10.9K 0.15% 177
2013
Q3 		$1.12M Buy
+67,400
New +$997K 0.17% 164

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Essex Investment Management's OSIR Position: Q1 2014 in Review

Essex Investment Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2014, closing a stake of 68,083 shares — an estimated $1.09M sold.

Essex Investment Management first reported a position in OSIR in Q3 2013 and held it in 2 quarters. The position peaked at $1.12M in Q3 2013. 63 funds tracked by Wall St. Rank hold OSIR as of Q1 2014.

  • Essex Investment Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Essex Investment Management sold 68,083 Osiris Therapeutics, Inc. Common Stock shares in Q1 2014, an estimated $1.09M.
  • Essex Investment Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2013 and held it in 2 quarters.
  • Essex Investment Management's Osiris Therapeutics, Inc. Common Stock position peaked at $1.12M in Q3 2013.
  • 63 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2014.

Based on Essex Investment Management's 13F filing for Q1 2014, filed 28 Apr 2014.